Find out why Ronald Akili is on TIME's 2025 list of the 100 most influential leaders driving business climate action.

It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that Eddie Martucci transitioned to the role of Board chair, and Matt Franklin has been ...

Following positive top-line data released in May, Akili Interactive announced it will release its video game treatment for attention deficit hyperactivity disorder to adults who want to use it.

Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It's a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved ...

Akili, a company that makes a video game treatment for ADHD, will sell to Virtual Therapeutics for about $34 million, according to a Wednesday regulatory filing. The two companies will merge into a ...

In the not-so-distant future, will playing video games be part of the prescription for treating children with attention-deficit/hyperactivity disorder (ADHD)? That's ...

Editor's note: The original version of this story claimed that STARS-ADHD Adjunctive enrolled 2016 subjects, instead of 206. We apologize for this error. Digital ...

After nearly a decade of work, Akili Interactive received the green light from the FDA to market its video game as a treatment for ADHD. It wasn’t an easy feat, and the company still has a long road ...